Soleno Therapeutics Inc Free Cash Flow Generation Index

Latest as of March 2026: 1.00x

Soleno Therapeutics Inc free cash flow generation index. Soleno Therapeutics Inc (SLNO) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $25.94 Million represents 1% of operating cash flow ($25.98 Million).

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$25.94 Million

USD

Operating Cash Flow

$25.98 Million

USD

Capital Expenditures

$40.00K

USD

Free Cash Flow Generation Index of Soleno Therapeutics Inc (2025–2025)

Free cash flow generation index of Soleno Therapeutics Inc from 2025 to 2025. Historical FCF Generation Index trend for Soleno Therapeutics Inc across 1 annual periods. See Soleno Therapeutics Inc (SLNO) flexibility index to measure the company's free cash flow as a share of total liabilities.

Soleno Therapeutics Inc Free Cash Flow Generation Index by Year (2025–2025)

Soleno Therapeutics Inc free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for Soleno Therapeutics Inc. For the full cash flow conversion analysis, see SLNO operating cash flow.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2025	1.00x	$46.73 Million	$46.80 Million	$73.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).